Aurobindo Pharma Ltd Naproxen Export Data — India (DGFT 2022–2026)

Name: Aurobindo Pharma Ltd Naproxen Export Records India — #7 Exporter, 372 Shipments, $6.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Naproxen

India Pharmaceutical Trade Intelligence

$133.8M192 Suppliers76 CountriesHS 30049069

ExportsIndia → UNITED STATES42.1%India → CANADA21.1%

ImportsUNITED STATES → India$391.7K GERMANY → India$185.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN PHARMACEUTICALS

Aurobindo Pharma Ltd — Naproxen Exporter #7 | $6.3M Trade Value | TransData Nexus | TransData Nexus

Aurobindo Pharma Ltd — Naproxen Exporter Profile

Indian Pharmaceutical Exporter · #7 for Naproxen · $6.3M export value · DGFT Verified

Aurobindo Pharma Ltd is the #7 Indian exporter of Naproxen with $6.3M in export value and 372 verified shipments. Aurobindo Pharma Ltd holds a 4.7% market share in Naproxen exports across 3 countries.

Aurobindo Pharma Ltd — Naproxen Export Profile: Buyers & Destinations

Aurobindo Pharma Ltd Naproxen export treemap — buyers and destination countries | TransData Nexus

Where Does Aurobindo Pharma Ltd Export Naproxen?

Country	Value	Shipments	Share
MALTA	$5.8M	516	84.7%
UNITED KINGDOM	$461.7K	13	6.8%
UNITED STATES OF AMERICA	$352.4K	8	5.2%
NETHERLANDS	$214.4K	17	3.1%

Who Are the Top Buyers of Naproxen from Aurobindo Pharma Ltd?

Buyer	Country	Value	Orders
APL SWIFT SERVICES (MALTA) LTD.,	MALTA	$2.9M	291
APL SWIFT SERVICES MALTA LIMITED	MALTA	$1.0M	74
APL SWIFT SERVICES MALTA LTD	MALTA	$620.3K	52
APL SWIFT SERVICES (MALTA) LIMITED	MALTA	$478.6K	34
MILPHARM LIMITED	UNITED KINGDOM	$376.9K	9
APL SWIFT SERVICES (MALTA) LTD	MALTA	$335.6K	18
XXL SXXFT XXRVIXXS (XXLTAXXLIMXXED	MALTA	$279.6K	11
XXROBXXDO XXARMXXUSAXXNC	UNITED STATES OF AMERICA	$252.4K	6
APL SWIFT SERVICES (MALTA) LIMITED,	MALTA	$130.4K	32
XXROHXXLTHXXLC	UNITED STATES OF AMERICA	$100.0K	2

Aurobindo Pharma Ltd supplies Naproxen to 19 buyers globally. The largest buyer is APL SWIFT SERVICES (MALTA) LTD., (MALTA), followed by APL SWIFT SERVICES MALTA LIMITED (MALTA) and APL SWIFT SERVICES MALTA LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Naproxen Formulations Does Aurobindo Pharma Ltd Export?

Product Description / Formulation	Value	Shipments
NAPROXEN 500MG TABLETSNaproxen Aurobindo 500 mg tabletten30'S	$245.1K	8
NAPROXEN 500MG TABLETS(APO-NAPRO, 500 MG, TABLETKI)30'S	$229.2K	19
NAPROXEN 500MG TABLETS(Naproxen Aurobind	$219.2K	11
NAPROXEN 250MG TABLETS(Apo-Napro, 250 mg	$214.4K	12
NAPROXEN 500MG TABLETSApo-Napro 500 mg tabletki30'S	$213.2K	6
NAPROXEN 500MG TABLETS, (Naproxen Aurobi	$192.2K	6
NAPROXEN 500MG TABLETS(Apo-Napro, 500 mg	$186.9K	8
NAPROXEN 500MG TABLETS (NAPROXEN TABLETSBP 500 MG) 2X14'S	$179.0K	4
NAPROXEN 500MG TABLETS(Naproxeno Generis	$168.9K	11
NAPROXEN 500MG TABLETS(APO-NAPRO 500MG T	$163.0K	7

Aurobindo Pharma Ltd exports 271 distinct Naproxen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is NAPROXEN 500MG TABLETSNaproxen Aurobindo 500 mg tabletten30' with 8 shipments worth $245.1K.

How Does Aurobindo Pharma Ltd Compare to Nearest Naproxen Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	UNICHEM LABORATORIES LIMITED	$13.8M	276	1	$50.0K
5	GRANULES INDIA LIMITED	$8.5M	191	2	$44.3K
7	AUROBINDO PHARMA LTD ★	$6.3M	372	3	$16.9K
4	AMNEAL PHARMACEUTICALS PRIVATE LIMITED	$6.0M	119	1	$50.0K
8	MARKSANS PHARMA LIMITED	$5.1M	149	2	$34.3K

Aurobindo Pharma Ltd ranks #7 among 192 Indian Naproxen exporters. Average shipment value of $16.9K compared to the market average of $405.2K. The closest competitors by value are UNICHEM LABORATORIES LIMITED and GRANULES INDIA LIMITED.

Which Indian Ports Ship Naproxen Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	429	12.6%
SAHAR AIR CARGO ACC (INBOM4)	245	7.2%
SAHAR AIR	236	6.9%
DELHI AIR CARGO ACC (INDEL4)	211	6.2%
JNPT/ NHAVA SHEVA SEA	156	4.6%
HYDERABAD ICD	145	4.2%
VIZAG SEA	140	4.1%
BANGALORE AIR	128	3.7%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Naproxen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Aurobindo Pharma Ltd matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 555 individual customs records matching Aurobindo Pharma Ltd exporting Naproxen, covering 271 formulations to 5 countries via 19 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 76+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Naproxen

Naproxen

Aurobindo Pharma Ltd — Naproxen Exporter Profile

Aurobindo Pharma Ltd — Naproxen Export Profile: Buyers & Destinations

Where Does Aurobindo Pharma Ltd Export Naproxen?

Who Are the Top Buyers of Naproxen from Aurobindo Pharma Ltd?

What Is India's Total Naproxen Export Value and How Much Does Aurobindo Pharma Ltd Contribute?

What Is the Average Shipment Value for Aurobindo Pharma Ltd's Naproxen Exports?

How Does Aurobindo Pharma Ltd Compare to Other Indian Naproxen Exporters?

What Naproxen Formulations Does Aurobindo Pharma Ltd Export?

Regulatory Requirements: Exporting Naproxen to Key Markets

United Kingdom — MHRA

How Does Aurobindo Pharma Ltd Compare to Nearest Naproxen Exporters?

Which Indian Ports Ship Naproxen Exports?

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Naproxen Export Data from Aurobindo Pharma Ltd

Naproxen Stats

Related Analysis

Need Detailed Export Data?

Data Source